BioVie Inc.

• BioVie Inc. Estimates – NASDAQ:BIVI
  TradingView · 23 Oct 2026
• BioVie reports positive bezisterim trial results in Parkinson’s
  Investing.com · 20 Oct 2026
• BioVie showcases Long COVID and Parkinson’s data at ANA2026, with findings in Annals of Neurology
  Proactive financial news · 20 Oct 2026
• BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
  The Manila Times · 20 Oct 2026
• Small cap wrap: BioVie, Record Resources, GMG, Thistle Resources...
  Proactive financial news · 19 Oct 2026
• BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting
  The Manila Times · 19 Oct 2026
• BioVie to present Phase 2 trial results of bezi...
  Pluang · 14 Oct 2026
• BioVie Warrant (BIVIW) Slides 15% as $0.27 Support Comes Into Focus - Strong Buy Stocks
  https://www.siam.in/ · 08 Oct 2026
• BIVI Q3 2026 Earnings: BioVie Posts Narrower-Than-Expected Loss of $0.70 per Share - Tech Earnings Analysis
  https://www.siam.in/ · 05 Oct 2026
• BIVI - BioVie Inc. | News
  OTC Markets · 02 Oct 2026
• Form DEF 14A BIOVIE INC. For: 29 September By Investing.com
  Investing.com India · 29 Sep 2026
• BioVie Inc. (BIVI) Trades Flat at $1.54 as Shares Consolidate Between $1.46 and $1.62 - Death Cross
  https://www.siam.in/ · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →